B. Mercier

B. Mercier, D. Charron, P. Loiseau, 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

The "Normandy" variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene.

B. Mercier, C. Mazurier, C. Gaucher, 1991, Blood.

A cluster ofcystic fibrosis mutations inexon 17boftheCFTR gene:a site forrare

X. Estivill, L. Kalaydjieva, G. Novelli, 1994 .

Incidence of venous thromboembolism in psychiatric units.

B. Mercier, M. Walter, D. Mottier, 2012, Thrombosis research.

Phosphonocationic lipids in protein delivery to mice lungs.

C. Férec, C. Guillaume, P. Delépine, 2000, Journal of pharmaceutical sciences.

Phenotypic but not allelic ABO blood group association with risk of venous thrombosis

E. Oger, B. Mercier, D. Mottier, 2005, Thrombosis and Haemostasis.

Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.

X. de Lamballerie, P. Marcellin, J. Pawlotsky, 2000, Journal of virological methods.

Prevention of West Nile virus transmission by blood transfusion: a comparison of nucleic acid test screening assays

X. de Lamballerie, P. Gallian, P. de Micco, 2005, Transfusion.

Inherited thrombophilias and unexplained pregnancy loss: an incident case‐control study

B. Mercier, D. Mottier, M. Collet, 2009, Journal of thrombosis and haemostasis : JTH.

Association of common genetic variations and idiopathic venous thromboembolism

E. Oger, M. Audrézet, B. Mercier, 2010, Thrombosis and Haemostasis.

Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.

E. Oger, B. Mercier, D. Mottier, 2007, Thrombosis research.

Identification of two point mutations in the von Willebrand factor gene of three families with the ‘Normandy’variant of von Willebrand disease

B. Mercier, C. Mazurier, C. Gaucher, 1991, British journal of haematology.

HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker of unfavorable outcome.

J. Clèdes, B. Mercier, O. Raguénès, 1995, Tissue antigens.

Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients.

G. Novelli, C. Férec, W. Lissens, 1995, American journal of human genetics.

Fibrinogen Is not an Additional Risk Factor of Thromboembolic Disease in Factor V Leiden Patients

B. Mercier, J. Abgrall, C. Férec, 1999, Thrombosis and Haemostasis.

Genotype analysis of adult cystic fibrosis patients.

C. Férec, M. Audrézet, B. Mercier, 1993, Human molecular genetics.

Complete detection of mutations in cystic fibrosis patients of Native American origin

X. Estivill, P. Pignatti, C. Férec, 1994, Human Genetics.

Molecular analysis of the TP53 gene in Barrett's adenocarcinoma

C. Férec, M. Audrézet, B. Mercier, 1996, Human mutation.

Myocardial Infarction: Absence of Association with VNTR Polymorphism of GP Ibα

J. Blanc, B. Mercier, J. Mansourati, 2000, Thrombosis and Haemostasis.

Mutation and Polymorphism Report

J. Clèdes, B. Mercier, R. Perrichot, 2000 .

GBV‐C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals

F. Roudot-thoraval, B. Mercier, P. Biagini, 1999, Journal of medical virology.

Characterisation of 98 alleles in 105 unrelated individuals in the F8VWF gene.

B. Mercier, C. Mazurier, C. Gaucher, 1991, Nucleic acids research.

Screening blood donations for viral genomes: multicenter study of real‐ time simulation using pooled samples on the model of hepatitis C virus RNA detection

J. Pawlotsky, B. Mercier, P. Rouger, 1998, Transfusion.

Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.

M Claustres, W Lissens, X. Estivill, 1995, The New England journal of medicine.

Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses

C. Férec, M. Audrézet, B. Mercier, 1995, Human Genetics.

The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe.

L. Peltonen, M. Parmentier, A. Czeizel, 1998, Human molecular genetics.

Exclusion of anionic trypsinogen and mesotrypsinogen involvement in hereditary pancreatitis without cationic trypsinogen gene mutations.

C. Férec, M. Audrézet, B. Mercier, 1999, Scandinavian journal of gastroenterology.

Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis

C. Férec, M. Audrézet, B. Mercier, 2000, Journal of medical genetics.

Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis

A. Munnich, R. Salomon, P. Guillausseau, 1999, Journal of medical genetics.

The hereditary pancreatitis gene maps to long arm of chromosome 7.

C. Férec, B. Mercier, L. Bachner, 1996, Human molecular genetics.

Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing.

J. Pawlotsky, F. Roudot-thoraval, B. Mercier, 1999, Journal of virological methods.

Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deferens and related clinical entities.

S. Seneca, C. Férec, H. Tournaye, 1996, Human reproduction.

Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers

X. Estivill, L. Tsui, J. Zieleński, 1996, Human mutation.

Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis.

C. Férec, M. Audrézet, B. Mercier, 2001, Gastroenterology.

Family history as a risk factor for venous thromboembolism.

Dominique Mottier, Emmanuel Oger, Bernard Mercier, 2008, Thrombosis research.

Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene

Milan Macek, Ada Hamosh, Bernard Mercier, 1997, Human mutation.

Risk of multisystem disease in isolated ocular angioma (haemangioblastoma)

C. Férec, C. Tomaras, M. Audrézet, 1999 .

Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis

C. Férec, M. Audrézet, B. Mercier, 2001, Clinical genetics.

[A new case of hydatidiform mole occurring on one of the ova of a twin pregnancy].

A. Berrebi, B. Mercier, X. Monroziès, 1988, Revue francaise de gynecologie et d'obstetrique.

Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis

C. Férec, A. Chaventré, M. Audrézet, 2000, The Lancet.

A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models.

E. Denamur, C. Férec, G. Lecointre, 2001, Molecular biology and evolution.

Neuropathies motrices pures post-radiques: 6 cas.

N. Birouk, T. Maisonobe, P. Bouche, 1998 .

[Pure motor neuropathy after radiation therapy: 6 cases].

N. Birouk, T. Maisonobe, N. le Forestier, 1998, Revue neurologique.

A cluster of cystic fibrosis mutations in exon 17b of the CFTR gene: a site for rare mutations.

X. Estivill, L. Kalaydjieva, G. Novelli, 1994, Journal of medical genetics.

Identification of six novel mutations in the CFTR gene of patients from Bulgaria by screening the twenty seven exons and exon/intron boundaries using DGGE and direct DNA sequencing.

L. Kalaydjieva, B. Mercier, C. Férec, 1994, Human molecular genetics.

Identification of three novel cystic fibrosis mutations in a sample of Italian cystic fibrosis patients.

B. Dallapiccola, G. Novelli, F. Sangiuolo, 1993, Human heredity.

Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene.

B. Dallapiccola, G. Lenoir, L. Kalaydjieva, 1993, Genomics.

Prevalence of GBV C/HGV RNA and GBV C/HGV Antibodies in French Volunteer Blood Donors: Results of a Collaborative Study

P. de Micco, D. Ouzan, R. Césaire, 1999, Vox Sanguinis.

High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors

F. Roudot-thoraval, B. Mercier, Y. Brossard, 2000, Transfusion.

Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13

M. Corey, X. Estivill, L. Tsui, 1999, Nature Genetics.

Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies

C. Férec, J. Andrieux, M. Audrézet, 2002, Journal of medical genetics.

Strong evidence that the N21I substitution in the cationic trypsinogen gene causes disease in hereditary pancreatitis

C. Férec, B. Mercier, J. Chen, 1999, Gut.

Asymptomatic carrier of two CFTR mutations: Consequences for prenatal diagnosis?

C. Férec, M. Audrézet, B. Mercier, 1993, Prenatal diagnosis.

Detection of over 98% cystic fibrosis mutations in a Celtic population

C. Férec, M. Audrézet, B. Mercier, 1992, Nature Genetics.

Absence of mutations in the interspecies conserved regions of the CFTR promoter region in cystic fibrosis (CF) and CF related patients.

E. Denamur, C. Férec, J. Elion, 1998, Journal of medical genetics.

patients . region in cystic fibrosis ( CF ) and CF related conserved regions of the CFTR promoter Absence of mutations in the interspecies

E. Denamur, C. Férec, J. Elion, 2022 .

Neonatal Screening for Cystic Fibrosis in Brittany, France: Assessment of 10 Years’ Experience and Impact on Prenatal Diagnosis

C. Férec, A. Chaventré, M. Audrézet, 2001 .

Novel mutations in the duplicated region of PKD1 gene

J. Clèdes, B. Mercier, I. Quéré, 2000, European Journal of Human Genetics.

Complete screening of mutations in the coding sequence of the CFTR gene in a sample of CF patients from Russia: Identification of three novel alleles

C. Férec, M. Audrézet, B. Mercier, 1995, Human mutation.

Identification of 12 novel mutations in the CFTR gene.

C. Férec, M. Audrézet, B. Mercier, 1993, Human molecular genetics.

Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study

E. Oger, B. Mercier, L. Gourhant, 2007, Journal of thrombosis and haemostasis : JTH.

Methylenetetrahydrofolate Reductase C677T Genotype and Venous Thromboembolic Disease

E. Oger, B. Mercier, D. Mottier, 2000, Respiration.

Linkage disequilibrium between the four most common cystic fibrosis mutations and microsatellite haplotypes in the Celtic population of Brittany

G. Bertorelle, C. Férec, A. Chaventré, 1996, Human Genetics.

Association of 1078 del T cystic fibrosis mutation with severe disease.

M. Audrézet, B. Mercier, I. Quéré, 1994, Journal of medical genetics.

DGGE screening of PKD1 gene reveals novel mutations in a large cohort of 146 unrelated patients.

C. Férec, J. Clèdes, B. Mercier, 1999 .

Inheritance of a Stable Mutation in a Family with Early-Onset Disease

J. Clèdes, B. Mercier, L. de Parscau, 2001, Nephron.

DGGE screening of PKD1 gene reveals novel mutations in a large cohort of 146 unrelated patients

J. Clèdes, B. Mercier, R. Perrichot, 1999, Human Genetics.

Detection of more than 94% cystic fibrosis mutations in a sample of belgian population and identification of four novel mutations

C. Férec, W. Lissens, I. Liebaers, 1993, Human mutation.

Identification of six novel CFTR mutations in a sample of Italian cystic fibrosis patients.

B. Dallapiccola, G. Novelli, C. Férec, 1995, Molecular and cellular probes.

Screening for cystic fibrosis in dried blood spots of newborns.

C. Férec, M. Audrézet, B. Mercier, 1993, Molecular and cellular probes.

Cationic phosphonolipids as nonviral gene transfer agents in the lungs of mice.

C. Férec, J. Yaouanc, J. Clement, 1998, Human gene therapy.

Expertise of French Laboratories in Detection, Genotyping, and Quantification of Hepatitis C Virus RNA in Serum

J. Pawlotsky, F. Roudot-thoraval, J. Izopet, 2004, Journal of Clinical Microbiology.

Retrospective study of the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Guthrie cards from a large cohort of neonatal screening for cystic fibrosis

C. Férec, M. Audrézet, B. Mercier, 1994, Human Genetics.

A novel mutation in exon 3 of the CFTR gene

C. Férec, M. Audrézet, B. Mercier, 1993, Human Genetics.

From Blood Stain to Pathogenesis Study of Human Hereditary Diseases

C. Férec, M. Audrézet, B. Mercier, 1995 .

Detection of the Taq 1 polymorphism of the factor IX gene by P.C.R.

B. Mercier, C. Mazurier, C. Gaucher, 1991, Thrombosis Research.

A mutation in exon 7 of the CFTR gene is common in the western part of France.

C. Férec, M. Audrézet, B. Mercier, 1992, Journal of medical genetics.

Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.

Arie, X. Estivill, atherine, 1995, The New England journal of medicine.

Identification of three novel mutations (457 TAT→G, D192G, Q685X) in the Slovenian CF patients

C. Férec, M. Audrézet, B. Mercier, 1994, Human Genetics.

Erratum: Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers (Human Mutation (1996) 8 (149-159))

X. Estivill, L. Tsui, J. Zieleński, 1996 .

Mild pulmonary, but severe hepatic disease in a cystic fibrosis patient homozygous for a frameshift mutation in the regulatory domain of the CFTR.

C. Férec, W. Lissens, I. Liebaers, 1993, Journal of medical genetics.

A polymorphism in intron 20 of the CFTR gene.

C. Férec, M. Audrézet, B. Mercier, 1991, Nucleic acids research.

Identification of two novel mutations in the CFTR gene: 3007 del G and 3271 +1 G→A

C. Férec, B. Mercier, I. Quéré, 1994, Human mutation.

[1691 G to A mutation of the factor V gene: no association with thrombosis of the central retinal vein].

B. Mercier, J. Abgrall, O. Raguénès, 1996, Presse medicale.

An MspI polymorphism in the von Willebrand factor gene.

B. Mercier, C. Mazurier, C. Gaucher, 1990, Nucleic Acids Research.

Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination

J. Pawlotsky, G. Duverlie, J. Izopet, 2007, Journal of Clinical Microbiology.

Identification of two novel mutations in the CFTR gene: 3007 del G and 3271 +1 G→A

C. Férec, B. Mercier, I. Quéré, 1994, Human Mutation.

Caecum: A Potential Site for Studying Gene Transfer in vivo

C. Férec, C. Guillaume, P. Delépine, 2000 .

[Glioblastoma after radiotherapy of meningioma].

B. Mercier, E. Lebiez, C. Duyckaerts, 1991, Revue neurologique.

Mild pulmonary, but severe hepatic disease in a cystic fibrosis patient homozygous for a frameshift mutation in the regulatory domain of the CFTR.

C. Férec, W. Lissens, I. Liebaers, 1993, Journal of medical genetics.